Zhang et al. demonstrated that in patients transplanted with NrasG12D/+p53−/− bone marrow cells, p53−/− synergizes with enhanced oncogenic Nras signaling to convert MEPs and promote AML development [9]. This evidence concerns the gene TP53 and acute myeloid leukemia.